Sudden Cardiac Death in the Young Athlete

Start Page: 
6
End page: 
8
Author(s): 

Peter T. Burke, MD, Hazim Al-Ameri, MD, Christian Machado, MD, FACCP, FAHA
Providence Heart Institute, Providence Hospital
Southfield, Michigan

A. E. Housman’s celebrated literary work, “To an Athlete Dying Young,” romanticizes the premature death of a young athlete. The poem reveals the concept that those dying at the peak of one’s glory or youth are actually quite lucky. This horrifying and ill-fated phenomenon in apparently healthy, young athletes is often the result of sudden cardiac death (SCD). The sobering reality, however, is that young athletes are dying from SCD with a frequency that is much higher than originally thought.1-6 Regrettably, there is obviously nothing “lucky” about dying at the peak of one’s youth.

This past fall, Detroit, Michigan was witness to SCD in two young athletes during the city’s annual marathon. These occurred just months after the Baltimore marathon claimed the life of a 23-year-old runner. The surrounding community was shocked and devastated with the news that the two young, well-conditioned runners, both under the age of 36, had collapsed within a couple miles of one another. The Wayne County medical examiner's office listed cardiac dysrhythmia as the cause of death.

The concept that young, healthy individuals who epitomize invulnerability could be subject to potential lethal cardiovascular disease and subsequent sudden death is not only counterintuitive, but quite disturbing. Accordingly, we need to increase awareness within the community to the causes of SCD, provide comprehensive and cost-effective screening strategies to the population at risk, and provide easier access to resuscitation equipment at all athletic venues.7-9

Incidence, Prevalence and Distribution of SCD

SCD is defined as death due to any cardiac disease within 1 hour after the onset of symptoms.10 SCD may be due to arrhythmic causes (e.g., ventricular fibrillation [VF], ventricular tachycardia [VT], or asystole) or non-arrhythmic causes (e.g., pulmonary embolus or rupture of the sinus of Valsalva).

The true prevalence of SCD is difficult to determine, as a significant percentage of cases are underreported.1-9 Relying on media reporting may also grossly underestimate the true incidence, since lower profile, non-elite athlete cases are more likely to be overlooked or unrecognized by the public and press. Estimates for runners range from 1 in 15,000 joggers and 1 in 50,000 marathon runners, representing 1 death per 50,000 to 375,000 man-hours of exercise.11

Sudden death is more common in male athletes, approximately 9 to 1, probably because young women have lower rates of participation in certain sports.1,12 This also may be explained by the disproportionate rate of recognition of hypertrophic cardiomyopathy (HCM) in women.13 One of the largest demographic studies of SCD in athletes demonstrated an equal distribution among different ethnic groups.14 When SCD in athletes is categorized according to etiology, HCM occurs more commonly in males than females and in African-American athletes than in Caucasian athletes, whereas aortic valve stenosis and arrhythmogenic right ventricular cardiomyopathy (ARVC) occurs with more prevalence in Caucasian athletes.1,14-15

References: 

1. Maron BJ, Shirani J, Poliac L, et al. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 1996;276:199-204.

2. Maron BJ. Cardiovascular risks to young persons on the athletic field. Ann Intern Med 1998;129:379-386.

3. Corrado D, Thiene G, Nava A, et al. Sudden death in young competitive athletes: Clinicopathologic correlations in 22 cases. Am J Med 1990;89:588-596.

4. Drory Y, Turetz Y, Hiss Y, et al. Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 1991;68:1388-1392.

5. Liberthson RR. Sudden death from cardiac causes in children and young adults. N Engl J Med 1996;334:1039-1044.

6. Maron BJ, Mitten MJ, Quandt EK, Zipes DP. Competitive athletes with cardiovascular disease — the case of Nicholas Knapp. N Engl J Med 1998;339:1632-1635.

7. Maron BJ, Thompson PD, Puffer JC, et al. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation 1996;94:850-856.

8. 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities: January 6-7, 1994. J Am Coll Cardiol 1994;24:845-899. [Erratum, Med Sci Sports Exerc 1994;26(10 Suppl):S223-83.]

9. Burke AP, Farb A, Virmani R, et al. Sports-related and non-sports-related sudden cardiac death in young adults. Am Heart J 1991;121:568-575.

10. Goldberger JJ, Cain ME, Hohnloser SH, et al. AHA/ACC/HRS scientific statement on non-invasive risk stratification techniques for identifying patients at risk for sudden cardiac death: A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation 2008;118:1497-1518.

11. Willich SN, Maclure M, Mittleman M, et al. Sudden cardiac death. Support for a role of triggering in causation. Circulation 1993;87:1442-1450.

12. Van Camp SP, Bloor CM, Mueller FO, Cantu RC, Olson HG. Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc 1995;27:641-647.

13. Maron BJ, Bonow RO, Cannon RO 3rd, et al. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 1987;316:780-789, 844-852.

14. Maron BJ. Sudden death in young athletes. N Engl J Med 2003;349:1064-1075.

15. Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998;339:364-369.

16. Wigle ED, Sasson Z, Henderson MA, et al. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis 1985;28:1-83.

17. Maron BJ. Hypertrophic cardiomyopathy: A systematic review. JAMA 2002;287:1308-1320.

18. Seidman JG, Seidman CE. The genetic basis for cardiomyopathy: From mutation identification to mechanistic paradigms. Cell 2001;104:557-567.

19. Ehsani AA, Hagberg JM, Hickson RC. Rapid changes in left ventricular dimensions and mass in response to physical conditioning and deconditioning. Am J Cardiol 1978;42:52-56.

20. Maron BJ, Pelliccia A, Spataro A, Granata M. Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes. Br Heart J 1993;69:125-128.

21. Maron BJ, Roberts WC, McAllister HA, et al. Sudden death in young athletes. Circulation 1980;62:218-229.

22. Maron BJ, Epstein SE, Roberts WC. Causes of sudden death in competitive athletes. J Am Coll Cardiol 1986;7:204-214.

23. Goldschlager N, Epstein AE, Grubb BP, et al. Etiologic considerations in the patient with syncope and an apparently normal heart. Arch Intern Med 2003;163:151-162.

24. Basso C, Maron BJ, Corrado D, Thiene G. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol 2000;35:1493-1501.

25. Post JC, van Rossum AC, Bronzwaer JG, et al. Magnetic resonance angiography of anomalous coronary arteries. A new gold standard for delineating the proximal course? Circulation 1995;92:3163-3171.

26. Machado C, Bhasin S, Soulen RL. Confirmation of anomalous origin of the right coronary artery from the left sinus of Valsalva with magnetic resonance imaging. Chest 1993;104:1284-1286.

27. Virmani R, Chun PK, Goldstein RE, et al. Acute takeoffs of the coronary arteries along the aortic wall and congenital coronary ostial valve-like ridges: Association with sudden death. J Am Coll Cardiol 1984;3:766-771.

28. Sen-Chowdhry S, Syrris P, McKenna WJ. Genetics of right ventricular cardiomyopathy. J Cardiovasc Electrophysiol 2005;16:927-935.

29. Thiene G, Nava A, Corrado D, et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988;318:129-133.

30. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000;343:1388-1398.

31. Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med 2003;348:1866-1874.

32. Brugada J, Brugada R, Antzelevitch C, et al. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002;105:73-78.

33. Wellens HJ, Rodriguez LM, Timmermans C, Smeets JP. The asymptomatic patient with the Wolff-Parkinson-White electrocardiogram. Pacing Clin Electrophysiol 1997;20:2082-2086.

34. Bharti S, Lev M. Congenital abnormalities of the conduction system in sudden death in young adults. J Am Coll Cardiol 1986;8:1096-1104.

35. Burke AP, Subramanian R, Smialek J, Virmani R. Nonatherosclerotic narrowing of the atrioventricular node artery and sudden death. J Am Coll Cardiol 1993;21:117-122.

36. Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002;106:69-74.

37. Maron BJ, Poliac L, Kaplan JA, Mueller FO. Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. N Engl J Med 1995;333:337-342.

38. Maron BJ, Link MS, Wang PJ, Estes NA 3rd. Clinical profile of commotio cordis: An underappreciated cause of sudden death in the young during sports and other activities. J Cardiovasc Electrophysiol 1999;10:114-120.

39. Link MS, Wang PJ, VanderBrink BA, et al. Selective activation of the K(+)(ATP) channel is a mechanism by which sudden death is produced by low-energy chest-wall impact (Commotio cordis). Circulation 1999;100:413-418.

40. Maron BJ, Gohman TE, Kyle SB, et al. Clinical profile and spectrum of commotio cordis. JAMA 2002;287:1142-1146.

41. Maron BJ, Carney KP, Lever HM, et al. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol 2003;41:974-980.

42. Nasir K, Bomma C, Tandri H, et al. Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: A need to broaden diagnostic criteria. Circulation 2004;110:1127-1134.

43. Maron BJ, Bodison SA, Wesley YE, et al. Results of screening a large group of intercollegiate competitive athletes for cardiovascular disease. J Am Coll Cardiol 1987;10:1214-1221.

44. Maron BJ. Sudden death in young athletes. Lessons from the Hank Gathers affair. N Engl J Med 1993;329:55-57.

image description image description


Anonymoussays: January 17.2010 at 15:01 pm

Outstanding and very informative article.

Reply to this comment »

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.